viral
test
perform
identifi
viru
first
patient
test
posit
antibodi
st
loui
enceph
sle
mosquitoborn
ill
mosquitocontrol
measur
institut
concurr
unusu
number
death
note
bird
primarili
crow
exot
captiv
bird
speci
bronx
zoo
new
york
citi
sinc
sle
caus
death
bird
human
bird
ill
thought
unrel
autopsi
perform
captiv
bird
die
bronx
zoo
reveal
vari
degre
meningoenceph
sever
myocard
tissu
specimen
neg
common
avian
pathogen
equin
enceph
virus
howev
nation
veterinari
servic
laboratori
ame
iowa
isol
viru
bird
tissu
forward
center
diseas
control
prevent
cdc
test
polymeras
chain
reaction
pcr
dna
sequenc
cdc
univers
california
irvin
indic
viru
close
relat
wnv
ident
viru
human
brain
tissu
enceph
case
new
york
retest
initi
serumcerebrospin
fluid
csf
specimen
reactiv
sle
posit
wnv
igm
enzymelink
immunosorb
assay
elisa
higher
positiveneg
ratio
sle
addit
patient
sampl
either
borderlin
neg
sle
posit
antibodi
wnv
confirm
wnv
inde
caus
ill
patient
west
nile
viru
recogn
unit
state
first
time
caus
epidem
enceph
mening
new
york
citi
ny
sinc
diseas
steadili
move
westward
human
case
recogn
blood
infect
woman
west
nile
provinc
known
uganda
investig
egypt
identifi
viru
bird
anim
addit
human
viru
recogn
caus
sever
meningoenceph
outbreak
nurs
home
resid
israel
subsequ
outbreak
wnv
infect
report
israel
africa
mild
consist
flulik
ill
mid
frequent
sever
outbreak
report
romania
russia
israel
meningoenceph
human
promin
featur
wnv
first
appear
unit
state
august
sinc
spread
nationwid
august
unusu
cluster
case
meningoenceph
associ
muscl
weak
notic
new
york
citi
ny
initi
epidemiolog
environment
investig
suggest
arthropodborn
viral
caus
arboviru
serolog
test
wnv
flaviviru
member
japanes
enceph
je
viru
serocomplex
contain
sever
virus
also
associ
human
enceph
je
sle
murray
valley
enceph
kunjin
subtyp
wnv
flavivirus
close
relat
antigen
account
serolog
crossreact
observ
member
je
complex
even
close
relat
often
special
test
need
differenti
infect
flaviviru
wnv
spheric
particl
approxim
nm
diamet
envelop
singlestrand
rna
viru
viral
membran
integr
glycoproteins
viral
envelop
membran
eglycoprotein
viral
hemagglutinin
mediat
virushost
cell
bind
elicit
virusneutr
antibodi
genet
analysi
indic
viru
respons
outbreak
extrem
similar
homolog
wnv
isol
dead
goos
israel
suggest
viru
probabl
origin
middl
east
unclear
viru
arriv
unit
state
like
explan
carri
infect
migrat
bird
possibl
infect
adult
mosquito
larva
inadvert
transport
airplan
human
extrem
lowlevel
viremia
infect
intern
travel
unlik
sourc
common
rout
wnv
infect
human
bite
infect
culicin
mosquito
mosquito
becom
infect
feed
infect
bird
high
level
wnv
blood
infect
mosquito
transmit
wnv
feed
human
anim
peopl
hors
mammal
develop
highlevel
viremia
henc
tradit
thought
deadend
host
wnv
detect
dead
bird
least
speci
bird
famili
corvida
crow
blue
jay
appear
particularli
suscept
wnv
peopl
risk
exposur
wnv
includ
work
outdoor
mosquito
activ
bite
farmer
forest
landscap
groundskeep
construct
outdoor
worker
wnv
transmit
person
person
mosquito
howev
new
mode
transmiss
recogn
describ
subsequ
recognit
new
mode
transmiss
invalid
theori
human
deadend
host
august
januari
confirm
case
wnv
transmiss
associ
blood
product
transfus
link
infecti
donor
unit
transmiss
wnv
document
occur
via
red
blood
cell
plasma
platelet
transfus
five
infect
donor
confirm
case
asymptomat
food
drug
administr
recommend
june
novemb
peak
transmiss
season
blood
bank
screen
potenti
blood
donor
headach
fever
past
week
defer
donat
day
case
wnv
infect
person
receiv
blood
transfus
week
becam
ill
report
blood
collect
agenc
cdc
addit
public
health
depart
blood
bank
cooper
identifi
blood
product
donor
develop
west
nile
viral
ill
give
blood
prompt
report
case
help
facilit
withdraw
potenti
infect
blood
compon
howev
symptom
occur
infect
patient
clinic
screen
limit
effect
henc
food
drug
administr
also
recommend
screen
donor
unit
wnv
use
nucleic
acid
test
august
transplant
recipi
receiv
organ
common
donor
develop
fever
meningoenceph
wnv
infect
diagnos
recipi
serum
plasma
sampl
drawn
organ
donor
time
organ
recoveri
posit
wnv
pcr
viru
cultur
organ
donor
receiv
blood
product
transfus
blood
donor
test
identifi
donor
viremia
time
donat
blood
blood
donor
also
transfus
patient
describ
septemb
woman
develop
wnv
meningoenceph
wnvme
day
receiv
postpartum
blood
transfus
wnvinfect
donor
csf
sampl
posit
wnvspecif
igm
breastfeed
newborn
sampl
breast
milk
obtain
day
deliveri
posit
wnv
pcr
wnvspecif
igg
igm
antibodi
newborn
remain
afebril
healthi
serum
sampl
newborn
day
show
wnvspecif
igm
antibodi
newborn
littl
outdoor
exposur
mosquito
suggest
infect
like
came
mother
breastfeed
benefit
breastfeed
well
establish
risk
transmiss
wnv
via
breastfeed
remain
quantifi
report
influenc
individu
decis
breastfe
wnv
infect
report
infant
breastf
report
advers
consequ
insect
repel
use
breastfeed
women
would
best
way
prevent
exposur
wnv
also
insectborn
ill
advers
pregnanc
outcom
report
previous
intrapartum
infect
je
dengu
wnv
august
previous
healthi
woman
week
pregnanc
admit
hospit
symptom
compat
wnvme
serum
csf
sampl
posit
wnvspecif
igm
deliv
live
newborn
week
later
infant
serolog
evid
wnv
infect
bilater
chorioretin
magnet
reson
imag
mri
evid
sever
bilater
white
matter
loss
tempor
occipit
lobe
pregnant
women
take
precaut
reduc
risk
wnv
arbovir
infect
avoid
mosquito
use
protect
cloth
insect
repel
wnv
transmiss
occur
area
pregnant
women
ill
clinic
consist
acut
wnv
infect
undergo
appropri
diagnost
test
screen
asymptomat
pregnant
women
newborn
evid
wnv
infect
recommend
specif
treatment
infect
avail
wnvigm
antibodi
might
persist
year
test
singl
serum
sampl
accur
determin
time
infect
cdc
initi
voluntari
registri
monitor
birth
outcom
among
wnvinfect
women
event
advers
birth
outcom
matern
fetal
newborn
sampl
submit
state
public
health
laboratori
cdc
test
report
case
occup
acquir
infect
among
laboratori
worker
associ
percutan
injuri
perform
autopsi
anim
wnv
surveil
patient
risk
factor
acquir
diseas
ill
mild
selflimit
recoveri
complet
sinc
wnv
epidem
number
laboratori
laboratori
worker
involv
arbovir
diagnost
activ
increas
dramat
increas
potenti
laboratoryacquir
infect
laboratori
worker
take
precaut
minim
exposur
potenti
infect
tissu
bodi
fluid
use
biosafeti
level
contain
work
live
wnv
unintent
exposur
wnv
occur
area
wash
thoroughli
soap
water
baselin
serum
sampl
obtain
store
worker
ill
within
next
week
medic
evalu
consult
public
health
offici
collect
addit
serum
sampl
test
recommend
case
wnv
diseas
hors
document
extens
case
occur
mortal
rate
approxim
hors
like
becom
infect
wnv
manner
human
ie
bite
infecti
mosquito
locat
wnv
circul
hors
protect
mosquito
bite
much
possibl
hors
vaccin
arbovirus
protect
wnv
infect
inactiv
wnv
equin
vaccin
innov
fort
dodg
anim
health
inc
overland
park
kan
receiv
full
licens
estim
efficaci
administr
dose
week
apart
annual
booster
start
mosquito
season
recommend
wnv
appear
caus
ill
dog
cat
although
serosurvey
indic
dog
infect
frequent
decemb
cdc
also
receiv
small
number
report
wnv
infect
bat
chipmunk
skunk
squirrel
domest
rabbit
animaltohuman
transmiss
report
report
fatal
wnv
ill
farm
allig
trace
contamin
meat
hors
infect
wnv
wnv
infect
viral
incub
period
human
rang
day
usual
period
day
human
infect
clinic
inappar
basi
seroepidemiolog
studi
infect
person
febril
ill
character
abrupt
onset
fever
headach
backach
myalgia
anorexia
typic
last
day
roseolar
maculopapular
rash
involv
primarili
face
trunk
occur
half
patient
last
week
gener
lymphadenopathi
common
seriou
nonneurolog
complic
human
occur
rare
includ
myocard
pancreat
fulmin
hepat
approxim
infect
person
sever
ill
central
nervou
system
cn
involv
advanc
age
import
risk
factor
neurolog
diseas
peopl
older
year
higher
risk
develop
neurolog
symptom
risk
time
higher
patient
older
year
meningoenceph
common
type
cn
present
isol
enceph
mening
also
occur
west
nile
virusassoci
acut
flaccid
paralysi
document
extens
patient
present
rel
young
weak
asymmetr
sensori
involv
weak
previous
attribut
peripher
demyelin
process
syndrom
new
studi
show
damag
local
spinal
anterior
horn
cell
result
poliomyelitislik
syndrom
patient
littl
improv
shortterm
followup
contrast
patient
syndrom
albuminocytolog
dissoci
patient
elev
protein
cell
csf
electromyographi
nerv
conduct
studi
also
help
make
distinct
newer
syndrom
report
outbreak
includ
movement
disord
tremor
myoclonu
parkinson
rhabdomyolysi
less
common
neurolog
manifest
includ
ataxia
cranial
nerv
involv
optic
neuriti
polyradiculopathi
seizur
report
one
third
patient
enceph
earlier
outbreak
common
featur
outbreak
unit
state
although
exact
mechan
uncertain
cn
infect
presum
occur
viru
cross
bloodbrain
barrier
endotheli
replic
axon
transport
olfactori
neuron
factor
enhanc
progress
cn
infect
among
elderli
person
may
includ
disrupt
bloodbrain
barrier
eg
hypertens
increas
durat
level
viremia
eg
immun
dysfunct
patient
without
neurolog
involv
gener
unev
recoveri
involv
cn
associ
mortal
longterm
morbid
new
york
citi
outbreak
patient
enceph
complet
recoveri
year
other
report
vari
degre
neurolog
impair
includ
fatigu
chronic
headach
memori
loss
difficulti
walk
muscl
weak
depress
identifi
cn
inflamm
mri
help
comput
tomographi
comput
tomograph
scan
patient
wnv
enceph
usual
show
normal
find
preexist
lesion
longterm
chang
patient
mri
show
leptomening
periventricular
enhanc
author
suggest
high
signal
intens
imag
thalamu
basal
ganglia
may
earli
indic
patient
wnv
enceph
fatal
case
patholog
find
diffus
inflamm
brain
spinal
cord
small
hemorrhag
perivascular
cuf
extens
neuron
degener
tabl
surveil
case
definit
wnv
infect
febril
ill
associ
neurolog
manifest
plu
least
follow
isol
wnv
demonstr
viral
antigen
genet
materi
tissu
bodi
fluid
igm
antibodi
wnv
csf
increas
antibodi
titer
wnv
pair
csf
serum
sampl
presenc
wnvspecif
igm
igg
antibodi
singl
serum
specimen
compat
ill
meet
laboratori
criteria
plu
least
follow
serum
igm
antibodi
wnv
elev
igg
antibodi
wnv
convalesc
serum
ill
meet
laboratori
criteria
plu
neg
test
result
igm
antibodi
wnv
serum
csf
collect
day
onset
ill
andor
neg
wnv
igg
antibodi
serum
collect
day
onset
ill
csf
cerebrospin
fluid
elisa
enzymelink
immunosorb
assay
wnv
west
nile
viru
detect
igm
captur
elisa
elisa
igg
sensit
nonspecif
confirm
plaqu
reduct
neutral
test
brainstem
especi
medulla
involv
extens
cranial
nerv
root
may
show
mononuclear
infiltr
laboratori
find
patient
may
either
mild
leukocytosi
mild
leukopenia
mild
hyponatremia
may
present
patient
especi
enceph
result
laboratori
studi
usual
normal
patient
wnvme
csf
find
includ
mild
pleocytosi
usual
rang
lymphocyt
predomin
mild
moder
protein
elev
normal
csf
glucos
level
infect
confirm
detect
viru
antibodi
viru
tabl
attempt
viru
isol
usual
unsuccess
level
viremia
extrem
low
clear
rapidli
figur
viremia
may
last
longer
patient
advanc
malign
take
immunosuppress
drug
serolog
test
perform
serum
csf
west
nile
virusspecif
igm
detect
serum
csf
igm
captur
elisa
least
patient
eighth
day
ill
igm
antibodi
appear
persist
month
ill
patient
may
persist
long
day
henc
contrari
infect
presenc
igm
antibodi
suggest
acut
infect
unless
associ
recent
compat
ill
igm
antibodi
cross
bloodbrain
barrier
thu
posit
find
csf
specif
cn
infect
except
case
csf
contamin
blood
traumat
spinal
tap
igg
antibodi
appear
seventh
day
ill
detect
week
infect
patient
acut
infect
igg
titer
increas
day
infect
falseposit
serolog
result
may
occur
patient
receiv
yellow
fever
je
vaccin
infect
virus
flaviviru
dengu
therefor
travel
histori
immun
histori
import
interpret
serolog
result
correctli
also
crossreact
sle
viru
occur
wide
unit
state
posit
igg
result
elisa
confirm
specif
testth
plaqu
reduct
neutral
test
viral
rna
detect
clinic
specimen
use
pcr
studi
patient
serolog
confirm
acut
wnvme
sensit
reversetranscriptasepcr
taqman
csf
serum
respect
fatal
wnvme
wnv
detect
brain
tissu
immunohistochemistri
pcr
cultur
techniqu
establish
treatment
wnv
infect
patient
wnvme
hospit
treatabl
cn
infect
condit
rule
patient
profound
muscl
weak
may
requir
intub
mechan
ventil
vitro
studi
shown
activ
ribavirin
interferon
alfa
pyrazidin
nucleosid
wnv
clinic
data
support
use
agent
present
intraven
immunoglobulin
wnvspecif
antibodi
shown
prophylact
therapeut
efficaci
wnv
infect
mice
day
onset
use
deetcontain
insect
repel
permethrin
consid
avoid
outdoor
activ
dusk
dawn
peak
mosquito
feed
time
use
addit
mosquito
precaut
time
possibl
wear
long
sleev
long
pant
sock
outdoor
maintain
window
door
screen
habitat
limit
number
place
around
home
mosquito
breed
dispos
item
hold
water
mosquito
work
local
govern
offici
establish
mosquito
control
program
kill
larva
adult
mosquito
anecdot
evid
efficaci
intraven
immunoglobulin
human
howev
support
care
includ
ventilatori
support
necessari
treatment
cerebr
edema
key
manag
measur
reduc
contact
human
potenti
infect
mosquito
way
reduc
infect
rate
morbid
mortal
due
wnv
infect
done
specif
person
protect
behavior
mosquitocontrol
activ
tabl
person
protect
measur
reduc
risk
infect
includ
follow
avoid
outdoor
activ
area
potenti
infect
mosquito
present
elimin
condit
support
mosquito
breed
eg
elimin
stand
water
clean
rain
gutter
maintain
window
door
screen
wear
longsleev
shirt
long
pant
outdoor
appli
insect
repel
contain
deet
n
ndiethylmtoluamid
permethrin
cloth
appli
deetcontain
repel
expos
skin
deet
broadspectrum
repel
effect
mani
speci
mosquito
bite
insect
durat
protect
provid
deet
proport
concentr
maximum
concentr
greater
provid
addit
benefit
deet
appli
cloth
expos
area
wash
return
indoor
overal
deet
good
safeti
profil
safe
use
infant
older
month
pregnant
women
current
avail
nondeet
repel
provid
satisfactori
reliabl
protect
mosquito
permethrin
synthet
pyrethroid
use
adjunct
deetcontain
insect
repel
permethrin
cloth
applic
origin
develop
cooper
use
us
militari
permethrin
odorless
dri
bind
tightli
fabric
one
applic
cloth
last
week
despit
sever
launder
addit
benefit
permethrin
activ
tick
bite
insect
inactiv
contact
skin
henc
deet
applic
expos
skin
neccessari
area
wnv
activ
bird
anim
human
local
govern
agenc
establish
mosquitocontrol
program
includ
appli
larvicid
water
collect
spray
adult
mosquito
control
two
candid
vaccin
wnv
evalu
one
vaccin
acambi
cambridg
mass
base
yellow
fever
vaccin
vaccin
develop
nation
institut
allergi
infecti
diseas
use
dengu
viru
backbon
carri
wnv
gene
vaccin
expect
test
phase
human
trial
late
infect
wnv
result
pronounc
human
econom
loss
sinc
wnv
first
appear
unit
state
year
saw
dramat
increas
number
case
widen
geograph
distribut
increas
period
case
occur
tabl
also
sever
new
mode
transmiss
new
clinic
present
recogn
ill
caus
substanti
morbid
elderli
person
immunosuppress
person
pregnant
women
group
take
special
precaut
mosquito
bite
manag
consist
support
care
specif
treatment
vaccin
current
avail
